219 related articles for article (PubMed ID: 27015568)
1. Influence of Body Mass Index and Albumin on Perioperative Morbidity and Clinical Outcomes in Resected Pancreatic Adenocarcinoma.
Hendifar A; Osipov A; Khanuja J; Nissen N; Naziri J; Yang W; Li Q; Tuli R
PLoS One; 2016; 11(3):e0152172. PubMed ID: 27015568
[TBL] [Abstract][Full Text] [Related]
2. Increasing body mass index portends abbreviated survival following pancreatoduodenectomy for pancreatic adenocarcinoma.
Mathur A; Luberice K; Paul H; Franka C; Rosemurgy A
Am J Surg; 2015 Jun; 209(6):969-73. PubMed ID: 25916614
[TBL] [Abstract][Full Text] [Related]
3. Impact of body mass index on perioperative outcomes and survival after resection for gastric cancer.
Ejaz A; Spolverato G; Kim Y; Poultsides GA; Fields RC; Bloomston M; Cho CS; Votanopoulos K; Maithel SK; Pawlik TM
J Surg Res; 2015 May; 195(1):74-82. PubMed ID: 25619462
[TBL] [Abstract][Full Text] [Related]
4. Preoperative Platelet-to-Albumin Ratio Predicts Prognosis of Patients with Pancreatic Ductal Adenocarcinoma After Pancreatic Resection.
Shirai Y; Shiba H; Haruki K; Horiuchi T; Saito N; Fujiwara Y; Sakamoto T; Uwagawa T; Yanaga K
Anticancer Res; 2017 Feb; 37(2):787-793. PubMed ID: 28179331
[TBL] [Abstract][Full Text] [Related]
5. The impact of obesity on outcomes following pancreatectomy for malignancy.
Benns M; Woodall C; Scoggins C; McMasters K; Martin R
Ann Surg Oncol; 2009 Sep; 16(9):2565-9. PubMed ID: 19557479
[TBL] [Abstract][Full Text] [Related]
6. The glasgow prognostic score as a predictor of survival in patients with potentially resectable pancreatic adenocarcinoma.
La Torre M; Nigri G; Cavallini M; Mercantini P; Ziparo V; Ramacciato G
Ann Surg Oncol; 2012 Sep; 19(9):2917-23. PubMed ID: 22488099
[TBL] [Abstract][Full Text] [Related]
7. Does body mass index/morbid obesity influence outcome in patients who undergo pancreatoduodenectomy for pancreatic adenocarcinoma?
Khan S; Sclabas G; Reid-Lombardo K; Sarr MG; Nagorney D; Kendrick ML; Que FG; Donohue JH; Huebner M; Lohse C; Farnell MB
J Gastrointest Surg; 2010 Nov; 14(11):1820-5. PubMed ID: 20676790
[TBL] [Abstract][Full Text] [Related]
8. Clinical and pathologic features influencing survival in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma.
Weber CE; Bock EA; Hurtuk MG; Abood GJ; Pickleman J; Shoup M; Aranha GV
J Gastrointest Surg; 2014 Feb; 18(2):340-7. PubMed ID: 24272772
[TBL] [Abstract][Full Text] [Related]
9. Determinants of survival after liver resection for metastatic colorectal carcinoma.
Parau A; Todor N; Vlad L
J BUON; 2015; 20(1):68-77. PubMed ID: 25778299
[TBL] [Abstract][Full Text] [Related]
10. Impact of obesity and body fat distribution on survival after pancreaticoduodenectomy for pancreatic adenocarcinoma.
Gaujoux S; Torres J; Olson S; Winston C; Gonen M; Brennan MF; Klimstra DS; D'Angelica M; DeMatteo R; Fong Y; House M; Jarnagin W; Kurtz RC; Allen PJ
Ann Surg Oncol; 2012 Sep; 19(9):2908-16. PubMed ID: 22411205
[TBL] [Abstract][Full Text] [Related]
11. Preoperative serum C-reactive protein levels and post-operative lymph node ratio are important predictors of survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
Sanjay P; de Figueiredo RS; Leaver H; Ogston S; Kulli C; Polignano FM; Tait IS
JOP; 2012 Mar; 13(2):199-204. PubMed ID: 22406601
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of weight loss in 1-year survivors after transthoracic esophagectomy for cancer.
D'Journo XB; Ouattara M; Loundou A; Trousse D; Dahan L; Nathalie T; Doddoli C; Seitz JF; Thomas PA
Dis Esophagus; 2012 Aug; 25(6):527-34. PubMed ID: 22121887
[TBL] [Abstract][Full Text] [Related]
13. Improved long-term outcomes after resection of pancreatic adenocarcinoma: a comparison between two time periods.
Serrano PE; Cleary SP; Dhani N; Kim PT; Greig PD; Leung K; Moulton CA; Gallinger S; Wei AC
Ann Surg Oncol; 2015 Apr; 22(4):1160-7. PubMed ID: 25348784
[TBL] [Abstract][Full Text] [Related]
14. The metastatic/examined lymph node ratio is an important prognostic factor after pancreaticoduodenectomy for pancreatic adenocarcinoma.
Berger AC; Watson JC; Ross EA; Hoffman JP
Am Surg; 2004 Mar; 70(3):235-40; discussion 240. PubMed ID: 15055847
[TBL] [Abstract][Full Text] [Related]
15. Smad4 inactivation predicts for worse prognosis and response to fluorouracil-based treatment in colorectal cancer.
Kozak MM; von Eyben R; Pai J; Vossler SR; Limaye M; Jayachandran P; Anderson EM; Shaffer JL; Longacre T; Pai RK; Koong AC; Chang DT
J Clin Pathol; 2015 May; 68(5):341-5. PubMed ID: 25681512
[TBL] [Abstract][Full Text] [Related]
16. [Prediction of prognosis of patients with pancreatic adenocarcinoma with curative intent resection by means of histologic grade and pathologic N stage].
Soriano-Izquierdo A; Adet AC; Gallego R; Miquel R; Castells A; Pellisé M; Nadal C; López-Boado MA; Piqué JM; Gascón P; Conill C; Bombí A; Fernández-Cruz L; Maurel J; Navarro S
Med Clin (Barc); 2009 Feb; 132(5):163-71. PubMed ID: 19211081
[TBL] [Abstract][Full Text] [Related]
17. Locally advanced pancreatic cancer: association between prolonged preoperative treatment and lymph-node negativity and overall survival.
Kadera BE; Sunjaya DB; Isacoff WH; Li L; Hines OJ; Tomlinson JS; Dawson DW; Rochefort MM; Donald GW; Clerkin BM; Reber HA; Donahue TR
JAMA Surg; 2014 Feb; 149(2):145-53. PubMed ID: 24306217
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of body mass index and change in body weight in postoperative outcomes of lung cancer surgery.
Nakagawa T; Toyazaki T; Chiba N; Ueda Y; Gotoh M
Interact Cardiovasc Thorac Surg; 2016 Oct; 23(4):560-6. PubMed ID: 27252238
[TBL] [Abstract][Full Text] [Related]
19. Does the extent of lymphadenectomy, number of lymph nodes, positive lymph node ratio and neutrophil-lymphocyte ratio impact surgical outcome of perihilar cholangiocarcinoma?
Hakeem AR; Marangoni G; Chapman SJ; Young RS; Nair A; Hidalgo EL; Toogood GJ; Wyatt JI; Lodge PA; Prasad KR
Eur J Gastroenterol Hepatol; 2014 Sep; 26(9):1047-54. PubMed ID: 25051217
[TBL] [Abstract][Full Text] [Related]
20. Increased preoperative platelet count is associated with decreased survival after resection for adenocarcinoma of the pancreas.
Brown KM; Domin C; Aranha GV; Yong S; Shoup M
Am J Surg; 2005 Mar; 189(3):278-82. PubMed ID: 15792750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
